Cellular and Molecular Neurobiology

, Volume 28, Issue 5, pp 643–652 | Cite as

Use of Anti-aging Herbal Medicine, Lycium barbarum, Against Aging-associated Diseases. What Do We Know So Far?

Original Paper

Abstract

Lycium barbarum (Gouqizi, Fructus Lycii, Wolfberry) is well known for nourishing the liver, and in turn, improving the eyesight. However, many people have forgotten its anti-aging properties. Valuable components of L. barbarum are not limited to its colored components containing zeaxanthin and carotene, but include the polysaccharides and small molecules such as betaine, cerebroside, β-sitosterol, p-coumaric, and various vitamins. Despite the fact that L. barbarum has been used for centuries, its beneficial effects to our bodies have not been comprehensively studied with modern technology to unravel its therapeutic effects at the biochemical level. Recently, our laboratory has demonstrated its neuroprotective effects to counter neuronal loss in neurodegenerative diseases. Polysaccharides extracted from L. barbarum can protect neurons against β-amyloid peptide toxicity in neuronal cell cultures, and retinal ganglion cells in an experimental model of glaucoma. We have even isolated the active component of polysaccharide which can attenuate stress kinases and pro-apoptotic signaling pathways. We have accumulated scientific evidence for its anti-aging effects that should be highlighted for modern preventive medicine. This review is to provide background information and a new direction of study for the anti-aging properties of L. barbarum. We hope that new findings for L. barbarum will pave a new avenue for the use of Chinese medicine in modern evidence-based medicine.

Keywords

Lycium barbsarum Anti-aging Neuroprotection Herbal medicine Polysaccharides 

References

  1. Bao X, Liu C, Fang J, Li X (2001) Structural and immunological studies of a major polysaccharide from spores of Ganoderma lucidum (Fr.) Karst. Carbohydr Res 332:67–74PubMedCrossRefGoogle Scholar
  2. Bao XF, Wang XS, Dong Q, Fang JN, Li XY (2002) Structural features of imunologically active polysaccharides from Ganoderma lucidum. Phytochemistry 59:175–181PubMedCrossRefGoogle Scholar
  3. Benzie IF, Chung WY, Wang J, Richelle M, Bucheli P (2006) Enhanced bioavailability of zeaxanthin in a milk-based formulation of wolfberry (Gou Qi Zi; Fructus barbarum L.). Br J Nutr 96:154–160PubMedCrossRefGoogle Scholar
  4. Butovsky O, Koronyo-Hamaoui M, Kunis G, Ophir E, Landa G, Cohen H, Schwartz M (2006) Glatiramer acetate fights against Alzheimer’s disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc Natl Acad Sci (USA) 103:11784–11789CrossRefGoogle Scholar
  5. Cao GW, Yang WG, Du P (1994) Observation of the effects of LAK/IL-2 therapy combining with Lycium barbarum polysaccharides in the treatment of 75 cancer patients. Zhonghua Zhong Liu Za Zhi 16:428–431PubMedGoogle Scholar
  6. Chan HC, Chang RCC, Ip AKC, Chiu K, Yuen WH, Zee SY, So KF (2007) Neuroprotective effects of Lycium barbarum Lynn on protecting retinal ganglion cells in an ocular hypertension model of glaucoma. Exp Neurol 203:269–273PubMedCrossRefGoogle Scholar
  7. Chang RCC, Suen KC, Ma CH, Elyaman W, Ng HK, Hugon J (2002a) Involvement of double-stranded RNA-dependent protein kinase and phosphorylation of eukaryotic initiation factor-2alpha in neuronal degeneration. J Neurochem 83:1215–1225PubMedCrossRefGoogle Scholar
  8. Chang RCC, Wong AK, Ng HK, Hugon J (2002b) Phosphorylation of eukaryotic initiation factor-2alpha (eIF2α) is associated with neuronal degeneration in Alzheimer’s disease. Neuroreport 13:2429–2432PubMedCrossRefGoogle Scholar
  9. Chen HS, Tsai YF, Lin S, Lin CC, Khoo KH, Lin CH, Wong CH (2004) Studies on the immuno-modulating and anti-tumor activities of Ganoderma lucidum (Reishi) polysaccharides. Bioorg Med Chem 12:5595–5601PubMedCrossRefGoogle Scholar
  10. Cheng CY, Chung WY, Szeto YT, Benzie IFF (2005) Fasting plasma zeaxanthin response to Fructus barbarum L. (Wolfberry; Kei Tze) in a food-based human supplementation trial. Br J Nutr 93:123–130PubMedCrossRefGoogle Scholar
  11. Chiu K, Ji JZ, Yu MS, Kwok NS, So KF, Chang RCC (2005) Differential effects of microglia/macrophages in the prevention of retinal ganglion cell loss in rats with laser-induced chronic ocular hypertension. Soc Neurosci Abstr 35:977.3Google Scholar
  12. Choi S, Kim KW, Choi JS, Han ST, Park YI, Lee SK, Kim JS, Chung MH (2002) Angiogenic activity of β-sitosterol in the ischaemia/reperfusion-damaged brain of Mongolian gerbil. Planta Med 68:330–335PubMedCrossRefGoogle Scholar
  13. Dai S, Wen R, Li W (1994) The values of Lycium barbarum to human being in antisenility and prolonging life-span. Geriatric Za Zhi 14:33–36Google Scholar
  14. Deng HB, Cui DP, Jiang JM, Feng YC, Cai NS, Li DD (2003) Inhibiting effects of Achyranthes bidentata polysaccharide and Lycium barbarum polysaccharide on nonenzyme glycation in D-galactose induced mouse aging model. Biomed Environ Sci 16:267–275PubMedGoogle Scholar
  15. Duan CL, Qiao SY, Wang NL, Zhao YM, Qi CH, Yao XS (2001) Studies on the active polysaccharides from Lycium barbarum L. Acta Pharmaceut Sinica 36:196–199Google Scholar
  16. Frasca D, Rilev RL, Blomberg BB (2005) Humoral immune response and B-cell functions including immunoglobulin class switch are downregulated in aged mice and humans. Sem Immunol 17:378–384CrossRefGoogle Scholar
  17. Gan L, Zhang S (2002) Effects of Lycium barbarum polysaccharide on cytokine expression in human monocytes. Acta Nutrimenta Sin 24:67–69Google Scholar
  18. Gan L, Zhang SH, Liu Q, Xu HB (2003) A polysaccharide-protein complex from Lycium barbarum upregulates cytokine expression in human peripheral blood mononuclear cells. Eur J Pharmacol 471:217–222PubMedCrossRefGoogle Scholar
  19. Gan L, Zhang SH, Yang XL, Xu HB (2004) Immunomodulation and antitumor activity by a polysaccharide-protein complex from Lycium barbarum. Intl Immunopharmacol 4:563–569CrossRefGoogle Scholar
  20. Go EK, Jung KJ, Kim JY, Yu BP, Chung HY (2005) Betain suppresses proinflammatory signaling during aging: the involvement of nuclear factor-κB via nuclear factor-inducing kinase/IκB kinase and mitogen-activated protein kinases. J Gerontol Biol Sci 60A:1252–1264Google Scholar
  21. Ha KT, Yoon SJ, Choi DY, Kim DW, Kim JK, Kim CH (2005) Protective effect of Lycium chinense fruit on carbon tetrachloride-induced hepatotoxicity. J Ethnopharmacol 96:529–535PubMedCrossRefGoogle Scholar
  22. Ho SC, Liu JH, Wu RY (2003) Establishment of the mimetic aging effect in mice caused by D-galactose. Biogerontology 4:15–18PubMedCrossRefGoogle Scholar
  23. Hu G, Bai H, Du S (1995) The effects of Chinese medicine Lycium barbarum (LB) on IL-2 production level and IL-2 receptors (α & β) expression. Chinese J Immunol 11:253–256Google Scholar
  24. Huang LJ, Liu Y, Jian GY, Ji GZ (1998) Isolation, purification and physio-chemical properties of immunoactive constituents from the fruit of Lycium barbarum L. Acta Pharmacol Sin 33:512–516Google Scholar
  25. Huang L, Tian G, Wang Z, Dong J, Wu M (2001) Studies on glycoconjugates and glycans from lycium barbarum in inhibiting low density lipoprotein (LDL) peroxidation. Acta Pharmaceut Sin 36:108–111Google Scholar
  26. Huang X, Yang M, Wu X, Yan J (2003) Study on protective action of lycium barbarum polysaccharides on DNA impairments of testicle cells in mice. J Hygiene Res 32:599–601Google Scholar
  27. Kanski J, Aksenova M, Stoyanova A, Butterfield DA (2002) Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: structure-activity studies. J Nutr Biochem 13:273–281PubMedCrossRefGoogle Scholar
  28. Kim SY, Lee EJ, Kim HP, Kim YC, Moon A, Kim YC (1999) A novel cerebroside from Lycii Fructus preserves the hepatic glutathione redox system in primary cultures of rat hepatocytes. Biol Pharm Bull 22:873–875PubMedGoogle Scholar
  29. Knopman D, Patterson M (2001) An open-label, 24-week pilot study of the methyl donor betain in Alzheimer disease patients. Alzheimer Dis Assoc Disord 15:162–165PubMedCrossRefGoogle Scholar
  30. Kuroiwa A, Liou S, Yan H, Eshita A, Naitoh S, Nagayama A (2004) Effects of a traditional Japanese herbal medicine, hochu-ekki-to (Bu-Shong-Yi-Qi Tang), on immunity in elderly persons. Intl Immunopharmacol 4:317–324CrossRefGoogle Scholar
  31. Li XM (2007) Protective effect of Lycium barbarum polysaccharides on streptozotocin-induced oxidative stress in rats. Int J Biol Macromol 40:461–465PubMedCrossRefGoogle Scholar
  32. Lin ZB, Zhang HN (2004) Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms. Acta Pharmacol Sin 25:1387–1395PubMedGoogle Scholar
  33. Li XM, Ma YL, Liu XJ (2007). Effect of the Lycium barbarum polysaccharides on age-related oxidative stress in aged mice. J Ethnopharmacol 111:504–511PubMedCrossRefGoogle Scholar
  34. Luo Q, Cai Y, Yan J, Sun M, Corke H (2004) Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium barbarum. Life Sci 76:137–149PubMedCrossRefGoogle Scholar
  35. Luo Q, Li Z, Huang X, Yan J, Zhang S, Cai YZ (2006) Lycium barbarum polysaccharides: Protective effects against heat-induced damage of rat testes and H2O2-induced DNA damage in mouse testicular cells and beneficial effect on sexual behavior and reproductive function of hemicastrated rats. Life Sci 79:613–621PubMedCrossRefGoogle Scholar
  36. Park MJ, Kim SR, Huh H, Jung JH, Kim YC (1994) Betain attenuates glutamate-induced neurotoxicity in primary cultured brain cells. Arch Pharm Res 17:343–347CrossRefGoogle Scholar
  37. Peng XD, Xiu DQ, Peng JZ, Liu CH (2002) Effects of Lycium barbarum polysaccharide on hippocampal activity in animals. J Ningxia Med Coll 24:79–81Google Scholar
  38. Peng XM, Huang LJ, Qi CH, Zhang YX, Tian GY (2001) Studies on chemistry and immuno-modulating mechanism of a glycoconjugate from Lycium barbarum L. Chinese J Chem 19:1190–1197CrossRefGoogle Scholar
  39. Peng Y, Ma C, Li Y, Leung KS, Jiang ZH, Zhao Z (2005) Quantification of zeaxanthin dipalmitate and total carotenoids in Lycium fruit (Frutus Lycii). Plant Foods Hum Nutr 60:161–164PubMedCrossRefGoogle Scholar
  40. Poon HF, Calabrese V, Scapagnini G, Butterfield DA (2004) Gree radical: key to brain aging and heme oxygenase as a cellular response to oxidative stress. J Gerontol (Med Sci) 59A:478–493Google Scholar
  41. Qin X, Yamauchi R, Aizawa K, Inakuma T, Kato K (2001) Structural features of arabinogalactan-proteins from the fruit of Lycium chinense Mill. Carbohydr Res 333:79–85PubMedCrossRefGoogle Scholar
  42. Ren B, Ma Y, Shen Y, Gao B (1995) Protective action of Lycium barbarum L. (LbL) and betaine on lipid peroxidation of erythrocyte membrane induced by H2O2. Zhong Guo Zhong Yao Za Zhi 20:303–304Google Scholar
  43. Schwartz M, Kipnis J (2005) Protective autoimmunity and neuroprotection in inflammatory and noninflammatory neurodegenerative diseases. J Neurosci 233:163–166Google Scholar
  44. Selkoe DJ (1993) Physiological production of the beta-amyloid protein and the mechanism of Alzheimer’s disease. Trends Neurosci 16:403–409PubMedCrossRefGoogle Scholar
  45. So KF, Chan HC, Chang RCC, Chan YM, Yuen WH, Zee SY (2005). Modulation of microglia by Chinese herbal medicine Lycium barbarum and neuroprotection of retinal ganglion cells in experimental glaucoma. Proceeding of 4th Asia-Pacific International Congress of Anatomists, pp 37Google Scholar
  46. Song Y, Wei G, Li C, Lu N (1995) Effect of Lycium barbarum polysaccharides on cerebral ischemia and reperfusion in mice. J Ningxia Med Coll 17:12–14Google Scholar
  47. Squier TC (2001) Oxidative stress and protein aggregation during biological aging. Exp Gerontol 36:1539–1550PubMedCrossRefGoogle Scholar
  48. Suen KC, Yu MS, So KF, Chang RCC, Hugon J (2003) Upstream signaling pathways leading to the activation of double-stranded RNA-dependent serine/threonine protein kinase in beta-amyloid peptide neurotoxicity. J Biol Chem 278:49819–49827PubMedCrossRefGoogle Scholar
  49. Sullivan PG, Brown MR (2005) Mitochondrial aging and dysfunction in Alzheimer’s disease. Prog Neuro-Psychopharmacol Biol Psychiat 29:407–410CrossRefGoogle Scholar
  50. Tan BK, Vanitha J (2004) Immunomodulatory and anti-microbial effects of some traditional Chinese medicinal herbs: a review. Curr Med Chem 11:1423–1430PubMedGoogle Scholar
  51. Wang L, Zhao C, Li X, Chien Y (1995) Isolation, purification, analysis and immunity effects of polysaccharide of Lycium barbarum. Acad J Kumming Med Coll 16:29–32Google Scholar
  52. Wang JH, Wang HZ, Zhang M, Zhang SH (2002a) Anti-aging function of polysaccharides from Fructus lycii. Acta Nutrimenta Sin 24:189–194Google Scholar
  53. Wang Y, Zhao H, Sheng X, Gambino PE, Costello B, Bojanowaski K (2002b) Protective effect of Fructus Lycii polysaccharides against time and hyperthermia-induced damage in cultured seminiferous epithelium. J Ethnopharmacol 82:169–175PubMedCrossRefGoogle Scholar
  54. Wang ZY, Huang XR, Qi MX (2003) The regulation of LBP (lycium barbarum polysaccharide, LBP) on the expression of apoptosis-related genes Bcl-2 and Bax in SD rat LEC (lens epithelial cells, LEC) induced by oxidative injuries. Chinese J Optomet Ophthalmol 5:147–149Google Scholar
  55. Wu SJ, Ng LT, Lin CC (2004) Antioxidant activation of some common ingredients of traditional Chinese medicine, Angelica sinensis, Lycium barbarum and Poria cocos. Phytother Res 18:1008–1012PubMedCrossRefGoogle Scholar
  56. Wu H, Guo H, Zhao R (2006) Effects of Lycium barbarum polysaccharide on the improvement of antioxidant ability and DNA damage in NIDDM rats. Yakugaku Zasshi 126:365–371PubMedCrossRefGoogle Scholar
  57. Xie C, Xu LZ, Li X M, Li KM, Zhao BH, Yang SL (2001) Studies on chemical constitutents in fruit of Lycium barbarum L. China. J Chinese Materia Medica 26:323–324Google Scholar
  58. Xu RR, Cao F, Liu ZX (2004) Clinical observation on treatment of acute myelocytic leukemia by supplementing qi, nourishing yin and clearing heat principle. Zhongguo Zhong Xi Yi Jie He Za Zhi 24:411–414PubMedGoogle Scholar
  59. Yankner BA (1996) Mechanisms of neuronal degeneration in Alzheimer’s disease. Neuron 16:921–932PubMedCrossRefGoogle Scholar
  60. Yu MS, Leung SKY, Lai SW, Che CM, Zee SY, So KF, Yuen WH, Chang RCC (2005) Neuroprotective effects of anti-aging oriental medicine Lycium barbarum against β-amyloid peptide neurotoxicity. Exp Gerontol 40:716–727PubMedCrossRefGoogle Scholar
  61. Yu MS, Ho YS, So KF, Yuen WH, Chang RCC (2006) Cytoprotective effects of Lycium barbarum against reducing stress on endoplasmic reticulum. Intl J Mol Med 17:1157–1162Google Scholar
  62. Yu MS, Lai CSW, Ho YS, Zee SY, So KF, Yuen WH, Chang RCC (2007) Characterization of the effects of anti-aging medicine Fructus lycii on β-amyloid peptide neurotoxicity. Int J Mol Med 20:261–268Google Scholar
  63. Zhao X, Raina AK, Rottkamp CA, Aliev G, Perry G, Boux H, Smith MA (2001) Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer’s disease. J Neurochem 76:435–441CrossRefGoogle Scholar
  64. Zhao H, Alexeev A, Chang E, Greenburg G, Bojanowski K (2005) Lycium barbarum glycoconjugates: effect on human skin and cultured dermal fibroblasts. Phytomedicine 12:131–137PubMedCrossRefGoogle Scholar
  65. Zhu J, Zhao LH, Zhao XP, Chen Z (2006) Lycium barbarum polysaccharides regulate phenotypic and functional maturation of murine dendritic cells. Cell Biol Intl 31:615–619CrossRefGoogle Scholar
  66. Zou S, Meadows S, Sharp L, Jan LY, Jan YN (2000) Genome-wide study of aging and oxidative stress response in Drosophila melanogaster. Proc Natl Acad Sci (USA) 97:13726–13731CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  1. 1.Laboratory of Neurodegenerative Diseases, Department of Anatomy, LKS Faculty of MedicineThe University of Hong KongPokfulamHong Kong SAR, China
  2. 2.Research Centre of Heart, Brain, Hormone and Healthy Aging, LKS Faculty of MedicineThe University of Hong KongPokfulamHong Kong SAR, China
  3. 3.Faculty of Medicine BuildingL1-49 Laboratory BlockPokfulamHong Kong

Personalised recommendations